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Reasons for non-participation in
malformation scans in Denmark: a cohort
study
Karina Hjort-Pedersen1,2,3* , Annette Wind Olesen3,4, Ester Garne5 and Lene Sperling3,4
Abstract
Background: The aim of the study was to estimate the proportion of women giving birth in two hospitals in the
Region of Southern Denmark who did not attend the malformation scan and to elucidate the reasons for not
participating.
Methods: In this register-based descriptive study, we used patient administration systems to identify women who
had given birth at two Danish hospitals between March 2013 and January 2015. We then linked this information
with the hospital database for fetal medicine (Astraia) to identify women who did not attend the malformation
scan at week 18–20. We reviewed the medical records of these women to validate the data and to identify the
reason for non-participation.
Results: Of 7690 births, 153 (2%) women did not attend the malformation scan. The main reason for non-participation
was a passive deselection (81%). Most of these women were not present in Denmark at the time of the malformation
scan (61%) and few women declined (8%).
Conclusions: Less than 2% of a birth cohort in two major hospitals in Denmark did not attend the free offer of a
malformation scan. Most of these women (81%) did not actively decide against the malformation scan. Very few
(0.2%) declined the malformation scan. Non-attendance is not always due to an active decision made by the
pregnant woman.
Keywords: Routine malformation scan, Second trimester, Non-participation, Ultrasound, National screening offer
Background
The malformation scan in the second trimester and the
combined first trimester screening (cFTS) are part of the
routine antenatal care offered in Denmark and have
been offered to all pregnant women since 2006 [1]. Less
than 5% of the population does not attend the malfor-
mation scan [2] and the reasons for non-participation
are unknown.
Denmark has historically had high participation in
prenatal diagnostics, even before implementation of the
prenatal screening program in 2004. The uptake rate of
the malformation scan has increased substantially from
61.6% in 2008 to 95.0% in 2014 [2]. Uptake of the cFTS
is similarly high, 93.9% in 2014 [2]. Nearly all (99%) of
these scans are performed in public hospitals [2]. Danish
studies on attitudes to prenatal testing and abortion have
shown that most people in Denmark have a positive
attitude to prenatal screening and a gradualistic attitude to
termination meaning that people in Denmark have a more
liberal attitude to abortion before the fetus becomes viable
but are less supportive of terminations late in pregnancy for
minor conditions [3, 4]. This could indicate that prenatal
screening is quickly accepted in the general population,
which is supported by a Dutch study on the populations
attitude to prenatal screening [5].
Participation in prenatal screening is high in Denmark
compared to other European countries also offering pre-
natal screening in the first and second trimester. Many
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studies have investigated factors influencing women’s
decision to accept or decline the cFTS [5–11]. Social,
religious and cultural factors are suggested to have
influence on the uptake rate. A Danish study from 1995
developed a tentative model of these factors suggesting
that the factors generally could be divided into societal
factors and personal factors. Societal factors were defined as
norms and ethics of society for example regarding abortion
and disabled people, public media coverage on prenatal
screening, attitudes of health services and clinicians,
attitudes of other pregnant women, availability of prenatal
screening. Personal factors include personal ethics, norms
and morality, religious conviction, time in pregnancy,
attitude of partner and friends, age, and previous pregnancy
experiences [12].
Organization and funding of the healthcare systems
seem to be important factors for participation. A study
by EUROCAT from 2008 comparing prenatal screening
policies in 18 European countries shows that there is a
marked difference in prenatal detection rates for Down’s
syndrome (DS) and neural tube defects (NTDs) among the
countries with and without a national screening program.
Detection rates were significantly higher in countries with
a national screening offer. However, having a national
screening policy did not ensure an equal offer of prenatal
screening to all women due to lack of resources, lacking
information to the pregnant women or lack of participa-
tion. Termination of pregnancy due to a fetal anomaly is
legal in most of the European countries, but the legal ges-
tational age limit for termination varies among countries
and is a considerable controversy in prenatal screening
[13]. The study also shows that even though abortion is
legal, uptake rate still differs considerably among these
countries suggesting that organizational and cultural
factors also influence participation in prenatal screening.
In the two countries where abortion was illegal a screening
program in the first trimester was not offered. However,
women were generally offered an ultrasound examination
in the second trimester where the fetus was examined for
congenital malformations.
Only a few studies have investigated factors influencing
the uptake rate of the malformation scan, and suggest that
the factors were slightly different from those related to the
cFTS. Age and ethnicity were associated with the cFTS
uptake but were not associated with the uptake of the
malformation scan [6, 14].
Although there are many similarities between the Danish
prenatal screening program and other European programs,
it is difficult to compare uptake rates due to differences in
health insurance programs, screening policies, abortion
legislation and culture.
Our assumption is that very few pregnant women actively
decline the routine malformation scan in Denmark and that
non-participation is due to other reasons. It is important to
investigate the reasons for non-participation to validate the
prenatal screening program in order to provide the best
prenatal care.
The aim of the study was to estimate the proportion
of women giving birth in two hospitals in the Region of
Southern Denmark who did not attend the malformation
scan and to elucidate the reasons for not participating.
Methods
Study design
The study was conducted as a retrospective cohort study
of women giving birth at Community Lillebaelt Hospital
(LH) and Odense University Hospital (OUH), between
March 2013 and December 2015.
Definition of the malformation scan
The aim of the malformation scan is to detect structural
fetal malformations that untreated are associated with a
considerable risk of intrauterine death, neonatal death or
increased morbidity and mortality in childhood [1]. The
malformation scan is performed in accordance with the
national guidelines by the Danish Fetal Medicine Society
(DFMS) [15]. All sonographers and doctors are certified
in accordance with the Fetal Medicine Foundation certifi-
cation to ensure that the malformation scan is performed
uniformly and systematically throughout Denmark [15].
The routine malformation scan is generally performed
between gestational week 18 and 20. If the pregnant
woman has an obstetric history with fetal malformations
or a medical condition with an increased risk of a fetal
malformation, she is offered an additional malformation
scan around gestational week 16. If specific severe mal-
formations are detected, termination of pregnancy is an
option after application.
In Denmark, pregnant women are informed about the
possibility of attending the cFTS and the malformation
scan at their first visit to the general practitioner. Their
decisions are documented in the pregnancy chart sent to
the obstetric departments [1].
We extracted data from the electronic record of ultra-
sound examinations (Astraia), the patient administration
system (PAS) and electronic medical records.
Data sources
Astraia (Astraia software gmbh, version 1.24.7, Germany,
https://www.astraia.com/en/) is a clinical ultrasound
database used by all public obstetric departments in
Denmark as an electronic medical record. Astraia con-
tains data on all ultrasound examinations performed in
pregnancy, biochemical data for the cFTS and maternal
background information.
PAS manages administrative paperwork in healthcare
organizations, mainly hospitals. The essential functions
are electronic booking and registration of the patient’s
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demographics (e.g. name, home address, date of birth)
and detailing all patient contacts with the hospital, both
outpatient and inpatient. Data from the patient adminis-
tration system are identical to data reported to the Danish
National Patient Registry. Consequently, we consider this
source data as valid [16].
We used the medical records to determine the reasons
for not attending the malformation scan. Medical records
consist of electronic admission notes, progress notes, dis-
charge notes, procedure notes, delivery notes, postpartum
notes and out-patient notes.
Study population
We identified women who had given birth in the two
hospitals in a two-year period. The study population was
pregnant women who did not attend the malformation
scan weeks 18–22 from the birth cohort. The women
were identified in PAS and Astraia using their civil registra-
tion numbers. By linking information from the International
Classification of Diseases and Related Health Problems
(ICD-10) diagnosis codes DO800-DO848 with ultrasound
data from Astraia we were able to identify our study
population (Fig. 1). As control group, we used pregnant
women from the birth cohort who had attended the
routine malformation scan at OUH and LH. Women
who had attended the malformation scan at another
hospital were not included in the control group (Fig. 1).
Medical records were reviewed and validated among
women without a registered routine malformation scan to
verify data and to identify the reasons for non-participation.
Danish experts in fetal medicine accept women who
attended the malformation scan at 21 + 0 to 21 +
6 weeks’ gestation as part of the control group even
though the examination is performed later than recom-
mended by the national guidelines.
Variables
Demographic characteristics of the study population
included maternal age, body mass index (BMI), country of
origin (Denmark/other), native language (Danish/other),
civil status (single/ cohabiting), smoking (yes/no), parity
(nulliparous/multiparous), first contact to a hospital (date
and gestational age), late malformation scan (gestational
age) and whether the child had a malformation (yes/no).
Reasons for non-participation in the routine malforma-
tion scan were obtained from medical records.
Data were registered in the database Research Electronic
Data Capture (REDCap 7.4.23 - © 2018 Vanderbilt
university) designed for the study.
Analysis
A Cubic spline was used to divide the variable years (ma-
ternal age) into four age groups and to determine which
group should be used as reference (Additional file 1).
Differences between the groups were assessed using χ2
tests and Fisher’s exact tests for categorical variables, and
independent-samples t-tests for continuous variables. A
two-sided p-value < 0.05 was considered to be statistically
significant. Logistic regression was used to calculate odds
ratios (OR). REDCap was used as a database for this study
and Stata 14 was used for statistical analysis.
Ethical aspects
The study was conducted in accordance with the regula-
tions of the Committee of Ethics and the use of medical
records for the study was approved by the Danish Health
Authority.
Results
The total number of births at LH and OUH was 7690 in
the defined study periods. Of these we identified 153
(2.0%) women who did not attend the malformation
scan between week 18 + 0 and 21 + 6.
Basic characteristics of the study population are sum-
marized in Table 1.
In the group of non-participants there were significantly
more women who were younger than 25, smoked and
were nulliparous. However, after multivariate logistic
Odense University Hospital
1 January 2014 - 1 January 2015
Births, n = 4388
Lillebaelt Hospital
1 March 2013 - 1 March 2014
Births, n = 3302
Cohort
Women not attending the
routine malformation scan
OUH, n = 93
LH, n = 60
Study population
Women attending the
routine malformation scan
at OUH and LH
Total, n = 6227
Control group
Women attending the
routine malformation scan
at another hospital
Total, n = 1310
Exclusion
Fig. 1 Flowchart study population BMC. Legend: Flowchart showing
the identification of women who did not attend the routine
malformation scans at Odense University Hospital (OUH) and
Lillebaelt Hospital (LH)
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regression analysis, being younger than 25 was the only
significant remaining factor (Table 2). Furthermore,
61% of the non-participants originated from a country
other than Denmark.
In the non-participants group two (1%) fetuses had a
congenital malformation. Both malformations were
detected prenatally, but after gestational age 21 + 6.
The majority (81%) of women did not actively decide
against the routine malformation scan. There were
numerous reasons for non-participation including, women
who immigrated to Denmark late in pregnancy, women
with late recognized pregnancy, women traveling or living
abroad at the time of the routine malformation scan and
women who knew they were pregnant yet had no contact
to the healthcare system before late in pregnancy (Fig. 2).
A common factor for these women is that they were not
informed about the possibility of having a malformation
scan mainly because they were not present in Denmark. A
small proportion (7%) of the women accepted a scheduled
appointment for the routine malformation scan but did
not show up for the scan. Only 12 (8%) women declined
the routine malformation scan which is less than 0.2% of
all the women giving birth (12 out of 7690). The category
other (11%) contains miscellaneous reasons, i.e. women
who declined the malformation scan because they were
tourists in Denmark and therefore had to pay. We could
not determine the reason of non-participation for 6 (4%)
of the women (Fig. 2).
The maternal characteristics of those who declined,
and those who did not actively decide against the rou-
tine malformation scan are presented in Table 3. In the
group of women who did not actively decide against
the routine malformation scan there was a significantly
larger number of women who spoke another language
and were nulliparous.
Discussion
To our knowledge, this is the first study investigating
reasons for non-participation in the routine malformation
scan in an unselected cohort of all women giving birth.
This descriptive study shows that very few pregnant
women did not attend the routine malformation scan (2%)
and that the main reason for non-participation was not an
active decision against prenatal screening (81%). Most of
these women (62%) were not present in Denmark at the
time of the malformation scan and 23% of these women
had a malformation scan after gestational age 22.
The participation rate in Denmark is high (98%) com-
pared with other European countries offering a similar
prenatal screening program (90% in the Netherlands and
Table 1 Maternal and pregnancy characteristics of participants
and non-participants of the malformations scan (gestational
week 18–21)
Non-participants Participants
Characteristics N (%)a N (%)a
Total 153 (2.4) 6227 (97.6)
Age (years) 27.8 (14–41) 29.5 (16–52)c
Smoking status
Yes 25 (16.3) 325 (10.0)c
No 125 (81.7) 5513 (88.5)
Unknown 3 (2.0) 89 (1.4)
Parity
Nulliparous 82 (53.6) 2621 (42.1)
Multiparous 70 (45.8) 3435 (55.2)c
Unknown 1 (0.7) 171 (2.8)
BMI
< 18.5 10 (6.5) 258 (4.1)
18.5–24.99 85 (55.6) 3522 (56.6)
25.00–29.99 26 (17.0) 1404 (22.6)
≥ 30.00 24 (15.7) 895 (14.4)
Unknown 8 (5.2) 148 (2.4)
Country of origin
Denmark 58 (37.9) N/Ab
Other 93 (60.8) N/Ab
Unknown 2 (1.3) N/Ab
BMI body mass index; adata are given as mean (range) or N (%); bdata not
available; cP < 0.05
Table 2 Univariable and multivariable logistic regression
analyses for prediction of non-participation in the routine
malformation scan by maternal characteristics
Univariable (n = 153) Multivariable (n = 153)
Variable OR (95% CI) p-value OR (95% CI) p-value
Agea
15–19 4.65 (2.28–9.46) < 0.05 3.51 (1.58–7.81) 0.002
20–24 2.13 (1.46–3.10) < 0.05 1.70 (1.12–2.57) 0.012
25–39 1.00 1.00
40–44 0.62 (0.15–2.53) 0.510 0.71 (0.17–2.90) 0.630
Smokingstatus
No 1.00 1.00
Yes 1.76 (1.14–2.73) < 0.05 1.53 (0.97–2.41) 0.069
Parity
Nulliparous 1.00 1.00
Multiparous 0.65 (0.03–0.04) 0.009 0.79 (0.55–1.12) 0.180
BMI
< 18.5 1.61 (0.82–3.13) 0.160 1.31 (0.66–2.59) 0.437
18.5–24.99 1.00 1.00
≥ 25.00 0.77 (0.49–1.20) 0.240 0.78 (0.50–1.21) 0.270
≥ 30.00 1.11 (0.70–1.76) 0.653 1.09 (0.38–1.72) 0.729
OR odds ratio, CI confidence interval, BMI body mass index; aage groups were
generated using a cubic spline (Additional file 1)
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93% in Sweden) [6, 14, 17]. Few studies have compared
the reasons for non-participation in the malformation
scan among countries. A Dutch cohort study based on a
questionnaire survey among pregnant women and mid-
wives found that women who identified themselves as
religious, were multiparous, had low education or low
income were less likely to attend the malformation scan
[6]. In our study, we found that women between the ages
of 15 and 25 and women originating from a country other
than Denmark were less likely to attend the malformation
scan. In the group of non-participants 61% were foreigners,
this is a considerably large percentage when compared to
the general population of the uptake area where the pro-
portion of immigrants is only 13% [18]. This is in line with
other studies and with clinical experience suggesting that
women declining prenatal screening more often originate
from non-western countries [6, 11, 19]. The differences in
the finding may be explained by the different study designs.
Our study population is based on an unselected cohort of
women giving birth, where the Dutch study is based on a
cohort of pregnant women attending midwifery practices.
Hence, they may have missed information on women who
did not attend the midwifery practices before birth.
In the group of non-participants 8% declined the mal-
formations scan. In this group there were significantly
more women who were multiparous and who spoke Danish,
in comparison to the group who did not actively decide
against it. The lack of significance in the analysis of some of
the other variables is presumably due to the small numbers.
A Danish nationwide survey from 2016 on characteris-
tics of non-participants of the cFTS found that these
women more often originated from a country other than
Denmark, spoke another language than Danish, were less
well educated and were more religious [11]. The main
reason for this difference may be due to different study
designs. The survey study had included a random sample
of 1000 women who had attended the cFTS and 1000
women who did not. Furthermore, the study suggests that
the main reasons for declining were a wish to continue
the pregnancy regardless of the test results, probably due
to ethical and religious reasons and being opposed to
abortion [11]. The proportion of non-participants of the
cFTS is slightly higher (6.1%) than non-participants of the
routine malformation scan (5%) [2]. We could speculate
that reasons for declining the routine malformation in
Denmark could be the same reasons as for the cFTS
because women who decline the malformation scan
often have declined the cFTS too.
Several studies investigating the uptake rate of the cFTS
suggest that organization and funding of the healthcare
system together with how the prenatal screening policy
is presented to the public are important factors for the
participation rate [3, 5, 6, 10]. A Dutch study comparing
participation rate of the cFTS in the Netherlands, England,
and Denmark identified two characteristics in the Dutch
screening program that are noticeably different from
the screening program in Denmark and may have a
considerable influence on the uptake rate. Firstly, there
is a charged fee of the cFTS for women under 36 years
of age in the Netherlands. The malformation scan is
free of charge, but not routinely offered as in Denmark.
Secondly, the right not to know seems to be more
important for some pregnant women in the Netherlands
[5]. This is in line with another Dutch study that states
11
8
5
7
7
12
15
35
0 10 20 30 40
Percent
Other
Declining
Late contact to the hospital
Non-attendence
Living abroad
Traveling
Late recognized pregnancy
Immigrants and refugees
Reasons non-participation
Passive deselection
Active deselection
Other
Fig. 2 Reasons non-participation BMC. Legend: Bar chart demonstrating the distribution of reasons for non-participation in the routine
malformation scans
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that women’s view on prenatal screening are highly influ-
enced by the social and cultural context in which it is
practiced [5, 20].
Sweden has a healthcare system and a national prenatal
screening program similar to Denmark. A Swedish study
from 2016 shows that the national guidelines on prenatal
screening have been interpreted in different ways within
the individual counties in Sweden causing the offer of
prenatal diagnosis to vary considerably across Sweden,
and whilst Denmark has an uptake rate of 95%, the
Table 3 Maternal characteristics of women declining the routine malformation scan compared with women passively deselecting
the routine malformation scan
All Active decliners Passive decliners
Variable N (%)a N (%)a N (%)a
Total number of women 153 12 124
Age (years) 27.8 (14–41) 30.6 (23–38) 27.5 (14–41)
Civil status
Single 29 (19.0) 4 (33.3) 33 (26.6)
Cohabiting 123 (80.4) 8 (66.7) 91 (73.4)
Unknown 1 (0.7) 0 (0.0) 0 (0.0)
Smoking status
Yes 25 (16.3) 4 (33.3) 18 (14.5)
No 125 (81.7) 8 (66.7) 104 (83.9)
Unknown 3 (2.0) 0 (0.0) 2 (1.6)
Parity
Nulliparous 82 (53.6) 2 (16.7) 75 (60.5)b
Multiparous 70 (45.8) 10 (83.3) 49 (39.5)
Unknown 1 (0.7) 0 (0.0) 0 (0.0)
BMI
< 18.5 10 (6.5) 1 (8.3) 7 (5.9)
18.5–24.99 85 (55.6) 6 (50.0) 71 (60.2)
25.00–29.99 26 (17.0) 2 (16.7) 22 (18.6)
≥ 30.00 24 (15.7) 3 (25.0) 18 (15.3)
Unknown 8 (5.2) 0 (0.0) 6 (4.8)
Country of origin
Denmark 58 (37.9) 8 (66.7) 48 (38.7)
Other 93 (60.8) 4 (33.3) 75 (60.5)
Unknown 2 (1.3) 0 (0.0) 1 (0.8)
Language
Danish 77 (50.3) 10 (83.3) 62 (50.0)b
Other than Danish 76 (49.7) 2 (16.7) 62 (50.0)
Gestational week first contact hospital 27 + 3 12 + 4 30 + 3
Late malformation scan
Yes 37 (24.2) 0 (0.0) 33 (26.6)
No 115 (75.2) 12 (100.0) 91 (73.4)
Unknown 1 (0.7)
Child with a malformation
Yes 2 (1.3) 0 (0.0) 2 (1.6)
No 150 (98.0) 12 (100.0) 121 (97.6)
Unknown 1 (0.7) 0 (0.0) 1 (0.8)
BMI body mass index; aData are given as mean (range) or N (%). Comparison of active and passive decliners by Fisher’s exact test: bP < 0.05
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uptake rate of the cFTS in Sweden was only 36.2 and
97% for the routine malformation scan [21, 22]. This
suggests that a national screening program does not
ensure equal access for all pregnant women if the offer
is not identical throughout the country [21]. A Dutch
study reflects that the Danish approach could cause the
offer to be perceived as a recommendation rather than
a choice [5]. However, a Danish study published in
2015 showed that 93% of the women attending the
cFTS made an informed choice [23]. We assume that
factors contributing to the difference in uptake rate of
the cFTS between Denmark and other countries can be
applied to the routine malformation scan because pregnant
women are informed about both examinations at the same
time [1].
Strengths include the use of an unselected cohort of
women giving birth contrary to a selected group of
women visiting ultrasound units. This has allowed us to
investigate the reasons for non-participation and not
only reasons for declining. Furthermore, due to the
national guidelines on prenatal screening, equal imple-
mentation and offer across Denmark, we assume similar
results would be obtained throughout Denmark and that
our findings cannot be explained by selection bias.
Data were validated by reviewing medical records
among all women who had given birth without a regis-
tered malformation scan. The study was limited to two
hospitals in Denmark which resulted in a low number of
non-participants. This may have impacted on the outcome
of the present study.
A potential limitation is that the review of the medical
records was conducted by one researcher. Possible mis-
interpretation and misclassification could be reduced
by double data entry.
Further, our study population consisted of women giving
birth at hospital. We may have missed women giving birth
at home (1% of all births in Denmark) and women who
had the malformation scan in a private setting (< 1% in
Denmark) [2, 24].
Our study showed that the main reason for non-par-
ticipation was not an active decision against the routine
malformation scan. We suggest that a late scan should be
offered regardless of the gestational age at the time of
referral because a prenatal diagnosis of a malformation
may change the management of the pregnancy, delivery
and postnatal treatment markedly. It will also give the
future parents a chance to prepare themselves for a child
with a malformation.
Conclusion
In this study we found that very few pregnant women
(< 2%) did not attend the free offer of a malformation
scan in two major hospitals in Denmark. Most of these
women (81%) did not make an active decision about
attending the malformation scan. More than 60% were
not present in Denmark when information about the
scan was given. Less than 0.2% declined the scan before
week 22. Being younger than 25 or originating from another
country was associated with non-attendance. Our findings
help to elucidate some of the reasons for non-participation
in a country with a national prenatal screening program
offered to all pregnant women. Furthermore, that reasons
for non-participation may be different from other countries
also offering prenatal screening, and non- attendance is not
always an active decision made by the pregnant woman.
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